Omidria FDA Approval History
FDA Approved: Yes (First approved May 30, 2014)
Brand name: Omidria
Generic name: ketorolac and phenylephrine
Dosage form: Injection
Company: Omeros Corporation
Treatment for: Intraocular Lens Replacement Procedures
Omidria (ketorolac and phenylephrine) is an anti-inflammatory and mydriatic combination added to irrigation solution during cataract surgery and intraocular lens replacement procedures.
Development timeline for Omidria
|Dec 12, 2017||Approval Omeros Corporation Announces FDA Approval of Omidria for Use in Pediatric Patients|
|Jun 2, 2014||Approval FDA Approves Omidria for Use in Cataract and Other Intraocular Lens Replacement Procedures|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.